Neurodegenerative Disorders: A Review
Hours: 1.00
Course Number: 0261
Neurodegenerative Disorders: A Review is a 1 hour continuing education course that reviews common types of neurodegenerative disorders including Alzheimer’s, Parkinson’s, Huntington’s, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis (ALS). Clinical characteristics and special care issues are addressed.
$ 3.50
Add to CartPurpose
The purpose of this course is to review common types of neurodegenerative disorders
Learning Objectives
- Review clinical characteristics of neurodegenerative diseases
- List special care issues that occur during late stage neurodegenerative disorders
- Discuss hospice and end of life care for individuals diagnosed with neurodegenerative disorders
Other people also viewed
| Course Title | Hours | Price | Buy Now |
|---|---|---|---|
Nurses Annual Subscription |
120 | $35.00 | Add to Cart |
Neurodegenerative Disorders CEU Bundle |
8 | $19.60 | Add to Cart |
Aging with HIV |
1 | $ 3.50 | Add to Cart |
AIDS and HIV: What Health Care Professionals Need to Know |
1 | $ 3.50 | Add to Cart |
Alzheimer's Disease & Dementia: A Brief Overview for Professional Caregivers |
1 | $ 3.50 | Add to Cart |
Managing Amyotrophic Lateral Sclerosis (ALS) in Senior Care |
1 | $ 3.50 | Add to Cart |
Managing Huntington's Disease in Senior Care |
1 | $ 3.50 | Add to Cart |
Managing Multiple Sclerosis in Senior Care |
1 | $ 3.50 | Add to Cart |
Managing Parkinson's Disease in Senior Care |
1 | $ 3.50 | Add to Cart |
Criteria for Successful Completion
To receive continuing education credit for this program, you must complete the entire course, including registration, viewing the video program, taking the post-test and obtaining a score of at least 70% or better, and completing the program evaluation. If you do not score a 70% or better, you may take the exam again as many times as necessary to receive a passing score. When a score of 70% or better is achieved, you will be able to move forward to the evaluation and receive your certificate online.